-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Speaker 2

Program: Spotlight Sessions
Session: Emicizumab’s Impact on the Landscape of Hemophilia A Treatment: Two Artists Debate the View
Hematology Disease Topics & Pathways:
Hemophilia, Diseases, Bleeding and Clotting
Saturday, December 5, 2020, 11:55 AM-12:00 PM

Robert F. Sidonio Jr., MD, MSc.

Children's Hospital of Atlanta, Atlanta, GA

Disclosures: Sidonio: Takeda: Research Funding.

<< Previous Presentation | Next Presentation